Education
About Us
Working with TipRanks
Follow Us
CareDx (CDNA)
NASDAQ:CDNA
Earnings Data
Report Date
May 01, 2025TBA Not Confirmed
Period Ending
2025 (Q1)Consensus EPS Forecast
-0.21Last Year’s EPS
-0.32Same Quarter Last Year
Moderate Buy
Based on 4 Analysts Ratings
---
Earnings Call Summary
Earnings Call Date:Feb 26, 2025
|% Change Since: -7.06%
|Next Earnings Date:May 01, 2025
Earnings Call Sentiment|Positive
The earnings call reflects a positive sentiment overall, with significant revenue growth, strong cash flow, and a notable legal victory. The company has successfully expanded its testing services and payer coverage. However, the guidance reflects caution due to possible seasonal impacts and a conservative ASP outlook.Company Guidance
During the CareDx, Inc. Fourth Quarter and Fiscal Year 2024 Earnings Conference Call, the company provided guidance for the upcoming fiscal year 2025, projecting revenue between $365 million and $375 million. They anticipate adjusted EBITDA gains ranging from $29 million to $33 million. CareDx aims to achieve $370 million in revenue for 2025 and has set a target to reach $500 million in revenue by 2027 with a 20% adjusted EBITDA margin. In the fourth quarter of 2024, the company reported $86.6 million in revenue, marking a 32% year-over-year increase. Testing Services revenue grew by 37% year-over-year, with approximately 45,500 tests conducted in the quarter, reflecting a 14% increase from the previous year. The company ended 2024 with a cash balance of $261 million and no debt, generating $22 million in cash from operations in the fourth quarter. Additionally, CareDx plans to continue its strategic investments in commercial operations to drive growth, expand payer coverage, and optimize business processes for long-term profitability.Record Revenue Growth
CareDx reported a quarterly revenue of $86.6 million, up 32% year-over-year, and a full-year 2024 revenue of $334 million, up 19% year-over-year. The company has set a 2025 revenue guidance of $370 million.
Strong EBITDA Performance
The company achieved $9.8 million in adjusted EBITDA in the fourth quarter and $27.8 million for the full year 2024, transitioning from a prior year adjusted EBITDA loss of $38 million.
Cash Flow and Financial Position
CareDx generated $22 million in cash from operations in Q4 2024, ended the year with a cash balance of $261 million, and no debt.
Testing Services Growth
The company delivered approximately 45,500 tests in Q4 2024, up 14% year-over-year, marking the sixth consecutive quarter of sequential testing services growth.
Expanded Payer Coverage
CareDx expanded coverage for AlloMap Heart and AlloSure, adding 28 million and 36 million new commercial covered lives respectively in 2024.
Legal Victory
The District Court reversed a prior $96 million jury verdict in a patent litigation case, resulting in a positive GAAP net income of $52.5 million for 2024.
---
CDNA Earnings History
The table shows recent earnings report dates and whether the forecast was beat or missed. See the change in forecast and EPS from the previous year.
Beat
Missed
---
CDNA Earnings-Related Price Changes
Report Date | Price 1 Day Before | Price 1 Day After | Percentage Change |
|---|---|---|---|
| Feb 26, 2025 | $21.10 | $21.06 | -0.19% |
| Nov 04, 2024 | $22.93 | $22.90 | -0.13% |
| Jul 31, 2024 | $19.99 | $23.58 | +17.96% |
| May 09, 2024 | $11.06 | $14.83 | +34.09% |
Earnings announcements can affect a stock’s price. This table shows the stock's price the day before and the day after recent earnings reports, including the percentage change.
---
FAQ
When does CareDx (CDNA) report earnings?
CareDx (CDNA) is schdueled to report earning on May 01, 2025, TBA Not Confirmed.
What is CareDx (CDNA) earnings time?
CareDx (CDNA) earnings time is at May 01, 2025, TBA Not Confirmed.
Where can I see when companies are reporting earnings?
You can see which companies are reporting today on our designated earnings calendar.
What companies are reporting earnings today?
You can see a list of the companies which are reporting today on TipRanks earnings calendar.
What is CDNA EPS forecast?
CDNA EPS forecast for the fiscal quarter 2025 (Q1) is -0.21.
---
